A third study, linking fibroblast-derived signaling to progression of DCIS, used normal mammary fibroblasts engineered to secrete hepatocyte growth factor (HGF), which was shown to increase the invasiveness of MCF10DCIS cells (10). This evidence concerns the gene HGF and ductal breast carcinoma in situ.